Therefore, a small molecule that can block the interaction between β-catenin and TCF4 can prevent the transcription of a variety of tumor-related proteins, such as c-myc, cyclin D1, Bcl-w, MDR1, IL-8 and ZEB1 [12,13,14,28,29,30]. This evidence concerns the gene TCF4 and neoplasm.